APA (7th ed.) Citation

N, T., VS, M., DA, B., G, K., E, L., D, P., . . . LA, I. (2024). VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis. Journal of the American Society of Nephrology : JASN, 35(3), 311. https://doi.org/10.1681/ASN.0000000000000292

Chicago Style (17th ed.) Citation

N, Tangri, et al. "VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis." Journal of the American Society of Nephrology : JASN 35, no. 3 (2024): 311. https://doi.org/10.1681/ASN.0000000000000292.

MLA (9th ed.) Citation

N, Tangri, et al. "VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis." Journal of the American Society of Nephrology : JASN, vol. 35, no. 3, 2024, p. 311, https://doi.org/10.1681/ASN.0000000000000292.